Hiroya Kitsunai

Impacts of Diabetes and an SGLT2 Inhibitor on the Glomerular Number and Volume in db/db Mice, as Estimated by Synchrotron Radiation Micro-CT at SPring-8

K. Uesugi, Y. Makino, Y. Saijo, 2018, EBioMedicine.

Hypoxia-inducible factor-1α is the therapeutic target of the SGLT2 inhibitor for diabetic nephropathy

T. Ota, Y. Takiyama, Y. Takeda, 2019, Scientific Reports.

Dipeptidyl peptidase-4 inhibitor treatment induces a greater increase in plasma levels of bioactive GIP than GLP-1 in non-diabetic subjects

Y. Makino, M. Haneda, T. Kieffer, 2016, Molecular metabolism.

A maternal high-fat diet induces fetal origins of NASH-HCC in mice

K. Uesugi, T. Sera, M. Hoshino, 2022, Scientific Reports.

Has the safety of diabetes therapy improved? Lessons from an analysis of diabetic medication-induced severe hypoglycemic cases in an emergency department from 2005 to 2013

M. Haneda, Y. Morikawa, A. Morikawa, 2016, Diabetology International.

A case of insulinoma diagnosed postpartum with hypoglycemic symptoms that were masked during pregnancy

K. Imai, M. Tanino, A. Abiko, 2021, Clinical case reports.

High glucose induces platelet‐derived growth factor‐C via carbohydrate response element‐binding protein in glomerular mesangial cells

Y. Makino, M. Haneda, Y. Fujita, 2016, Physiological reports.